Receipt of locoregional therapy among young women with breast cancer

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 893-906

  Freedman, Rachel A ^a   Virgo, Katherine S ^b   Labadie, Julia ^b   He, Yulei ^c   Partridge, Ann H ^a   Keating, Nancy L ^c,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Locoregional therapy; Radiation; Young women

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER THERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LOCOREGIONAL THERAPY; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT INDICATION;

ADOLESCENT; ADULT; BREAST NEOPLASMS; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MEDICAID; MEDICARE; MIDDLE AGED; ODDS RATIO; UNITED STATES; YOUNG ADULT;

EID: 84866555621     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2156-8     Document Type: Article

References (59)

1. Breast Cancer Facts and Figures 2011-2012. American Cancer Society. http://www.cancer.org/acs/groups/content/@epidemiolo gysurveilance/documents/ document/acspc-030975.pdf. Accessed 3 Oct 2011
2. Schairer C, Mink PJ, Carroll L, Devesa SS (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96(17):1311-1321 (Pubitemid 39264120)
3. SEER Cancer Statistics Review (1997-2007) 5-year relative survival (percent) 1999-2006 by age at diagnosis. http://seer. cancer.gov/csr/1975-2007/ browse-csr.php?section=4&page=sect- 04-table.14.html#table4. Accessed 11 March 2011
4. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113(1):109-113 (Pubitemid 36999799)
5. Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL, Buzdar AU, Hortobagyi GN, Theriault RL (2001) Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 92(10):2523-2528 (Pubitemid 33049434)
6. Zabicki K, Colbert JA, Dominguez FJ, Gadd MA, Hughes KS, Jones JL, Specht MC, Michaelson JS, Smith BL (2006) Breast cancer diagnosis in women \ or =40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol 13(8):1072-1077 (Pubitemid 44337966)
7. Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003) Breast cancer in young women: clinicopathological features and biological specificity. Breast 12(4):247-250 (Pubitemid 36944150)
8. Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (\35 years) are different. Br J Cancer 74(11):1796-1800 (Pubitemid 26401901)
9. Barber MD, Jack W, Dixon JM (2004) Diagnostic delay in breast cancer. Br J Surg 91(1):49-53 (Pubitemid 38122049)
10. Ruddy KJ, Gelber S, Tamimi R, Schapira L, Come S, Kereakoglow S, Lin NU, Winer EP, Partridge AH (2009) Presentation of breast cancer in young women. J Clin Oncol 27:15s (suppl; abstr 6608). 2009 ASCO Meeting
11. Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schafer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41(10):1446-1452 (Pubitemid 40826469)
12. Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315(9):559-563 (Pubitemid 16052469)
13. Jayasinghe UW, Taylor R, Boyages J (2005) Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg 75(9):762-767 (Pubitemid 43942660)
14. Han W, Kim SW, Park IA, Kang D, Youn YK, Oh SK, Choe KJ, Noh DY (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82
15. Muscolino G, Villani C, Bedini AV, Luini A, Salvadori B (1987) Young age is not an ominous prognostic factor in breast cancer patients. Tumori 73(3):233-235
16. Anderson BO, Senie RT, Vetto JT, Wong GY, McCormick B, Borgen PI (1995) Improved survival in young women with breast cancer. Ann Surg Oncol 2(5):407-415
17. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087-2106 (Pubitemid 41797643)
18. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. Breast Cancer. V.2.2011. http://www. nccn.org/professionals/physician- gls/PDF/breast.pdf. Accessed 10 July 2011
19. Early Breast Cancer Trialists' Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333(22):1444-1455
20. Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558-1564 (Pubitemid 26134214)
21. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233-1241 (Pubitemid 35176242)
22. Veronesi U (1990) NIH consensus meeting on early breast cancer. Eur J Cancer 26(7):843-844 (Pubitemid 20328563)
23. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ et al (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(5): 1539-1569 (Pubitemid 32203717)
24. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97(2): 116-126 (Pubitemid 40277091)
25. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 37(14):949-955 (Pubitemid 27425950)
26. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB et al (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353(9165):1641-1648 (Pubitemid 29224519)
27. Jobsen JJ, van der Palen J, Meerwaldt JH (2001) The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur J Cancer 37(15):1820-1827 (Pubitemid 32913307)
28. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, Harris JR (1988) The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14(1):3-10 (Pubitemid 18059122)
29. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29(29):3885-3891
30. Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC (2006) The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol 24(3): 361-369 (Pubitemid 46630454)
31. Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC (2008) Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys 72(5):1434-1440
32. Jagsi R, Abrahamse P, Morrow M, Hawley ST, Griggs JJ, Graff JJ, Hamilton AS, Katz SJ (2010) Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol 28(14):2396-2403
33. Jagsi R, Abrahamse P, Morrow M, Griggs JJ, Schwartz K, Katz SJ (2009) Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer 115(6):1185-1193
34. Freedman RA, He Y, Winer EP, Keating NL (2009) Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol 27(5):713-719
35. Bilimoria KY, Stewart AK, Winchester DP, Ko CY (2008) The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15(3):683-690
36. Commission on Cancer: The National Cancer Database (NCDB) http://www.facs.org/cancer/ncdb/ncdbabout.html. Accessed 10 Oct 2011
37. Sylvester M, Blankenship C, Carter A (2001) Quality control: the American College of Surgeons Commission on Cancer Standards, National Cancer Data Base, and Cancer Liaison Program. J Registry Manag 27:68-74
38. Eberle CP, Tary JP (1997) Quality management in the National Cancer Data Base: a re-abstracting study of the Midwest region. J Registry Manag 24:93-97
39. Mulnar K, Philips J, Fritz A (2001) Quality of oncology data: findings from the Commission on Cancer PCE Study. J Registry Manag 28:24-34
40. Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY (2009) Comparison of Commission on Cancer-Approved and -Nonapproved Hospitals in the United States: implications for Studies That Use the National Cancer Data Base. J Clin Oncol 27(5):4177-4181
41. Commission on Cancer: Facility Oncology Registry Data Standards (FORDS), revised for 2007. Chicago, IL, American College of Surgeons, 2007. http://www.facs.org/cancer/coc/fords/2007/ fordsrevised2007.pdf. Accessed 19 Dec 2011
42. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971-977 (Pubitemid 39166260)
43. Truong PT, Wong E, Bernstein V, Berthelet E, Kader HA (2004) Adjuvant radiation therapy after breast-conserving surgery in elderly women with early-stage breast cancer: controversy or consensus? Clin Breast Cancer 4(6):407-414 (Pubitemid 38443463)
44. Green F, Page D, Fleming I, Fritz A, Balch C, Haller D, Morrow M (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York
45. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383 (Pubitemid 17055592)
46. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613-619
47. Bhargava A, Du XL (2009) Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph nodepositive, operable breast cancer. Cancer 115(13):2999-3008
48. Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A et al (2012) Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30(2):142-150
49. Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL (2011) The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117(1):180-189
50. Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML (2005) Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23(36):9079-9088
51. Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A (2008) Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58(1):9-31
52. Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB (1998) Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 16(1):101-106 (Pubitemid 28041585)
53. Punglia RS, Weeks JC, Neville BA, Earle CC (2006) Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol 24(21):3474-3482 (Pubitemid 46638906)
54. Keating NL, Kouri E, He Y, Weeks JC, Winer EP (2009) Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care 47(7):765-773
55. Ruddy KJ, Gelber S, Tamimi R et al (2009) Prevalence and predictors of distress in young women with newly diagnosed early stage breast cancer. Presented at the San Antonio breast cancer symposium, San Antonio, TX, 10 December 2009. Abstract #1067
56. Ruddy KJ, Gelber S, Tamimi RM et al (2010) Coping strategies in young women with breast cancer. Presented at the 2010 American Society of Clinical Oncology Meeting (Chicago, IL). J Clin Oncol 28:15s (suppl; abstr 9159)
57. Schneider EC, Malin JL, Kahn KL, Emanuel EJ, Epstein AM (2004) Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol 22(15):2985-2991 (Pubitemid 41103710)
58. Meguerditchian AN, Stewart A, Roistacher J, Watroba N, Cropp M, Edge SB (2010) Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer. J Surg Oncol 101(7):593-599
59. Gross CP, Smith BD, Wolf E, Andersen M (2008) Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer 112(4):900-908 (Pubitemid 351240584)